John C. Thomas

Insider Reports History

Location
Raleigh, NC
Signature
/s/ Greg Duncan, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John C. Thomas:

Company Role Class Num Shares Value Price $ Report Date Ownership
ImmunityBio, Inc. Former Director Common Stock 202,477 $1,016,435 $5.02 23 Feb 2021 Direct
ImmunityBio, Inc. Former Director Common Stock 13,886 $69,708 $5.02 31 Dec 2021 Indirect
Dogwood Therapeutics, Inc. Director Stock Option (right to buy) 2,362 27 Jun 2025 Direct

Insider Reports Filed by John C. Thomas

Symbol Company Period Transactions Value $ Form Type Role Filing Time
DWTX Dogwood Therapeutics, Inc. 27 Jun 2025 1 $0 4 Director 01 Jul 2025, 14:02
DWTX Dogwood Therapeutics, Inc. 18 Jun 2025 2 $0 4 Director 23 Jun 2025, 11:59
DWTX Virios Therapeutics, Inc. 26 Feb 2024 1 $0 4 Director 28 Feb 2024, 13:09
DWTX Virios Therapeutics, Inc. 15 Jun 2023 1 $0 4 Director 20 Jun 2023, 14:01
DWTX Virios Therapeutics, Inc. 23 Jun 2022 1 $0 4 Director 30 Jun 2022, 14:01
DWTX Virios Therapeutics, Inc. 04 Jan 2022 1 +$5,650 4 Director 04 Jan 2022, 14:19
IBRX ImmunityBio, Inc. 31 Dec 2021 1 $0 5 Former Director 28 Jan 2022, 15:29
DWTX Virios Therapeutics, Inc. 22 Jun 2021 1 $0 4 Director 23 Jun 2021, 14:52